Editorial
Published on 24 Jan 2024
Editorial: Case reports in psychopharmacology
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2024.1364711
- 1,597 views
Type at least 3 characters
470 articles
Original Research
Published on 23 Jan 2024
Listening to music during intranasal (es)ketamine therapy in patients with treatment-resistant depression correlates with better tolerability and reduced anxiety
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2024.1327598
- 5,948 views
- 10 citations
Original Research
Published on 17 Jan 2024
The prevalence of off-label use and supratherapeutic blood levels of outpatient psychotropic medication in suicidal adolescents
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2023.1240681
- 2,811 views
Clinical Trial
Published on 16 Jan 2024
Comparing the efficacy of duloxetine and nortriptyline in alleviating the symptoms of functional dyspepsia – a randomized clinical trial
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2023.1297231
- 9,136 views
- 5 citations
Original Research
Published on 11 Jan 2024
Safety, tolerability, pharmacodynamic and wellbeing effects of SPL026 (dimethyltryptamine fumarate) in healthy participants: a randomized, placebo-controlled phase 1 trial
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2023.1305796
- 6,683 views
- 12 citations
Brief Research Report
Published on 11 Jan 2024
Prescribed psychotropic medication patterns among treated Foster Care enrollees: a single institution study
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2023.1278233
- 2,982 views
- 3 citations
Review
Published on 10 Jan 2024
A paradoxical switch: the implications of excitatory GABAergic signaling in neurological disorders
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2023.1296527
- 6,850 views
- 15 citations
Original Research
Published on 08 Jan 2024
In vivo validation of psilacetin as a prodrug yielding modestly lower peripheral psilocin exposure than psilocybin
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2023.1303365
- 8,543 views
- 8 citations
Original Research
Published on 08 Jan 2024
Potential therapeutic effects of an ayahuasca-inspired N,N-DMT and harmine formulation: a controlled trial in healthy subjects
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2023.1302559
- 11,858 views
- 23 citations
Perspective
Published on 05 Jan 2024
Perspectives on ADHD in children and adolescents as a social construct amidst rising prevalence of diagnosis and medication use
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2023.1289157
- 16,893 views
- 13 citations
Case Report
Published on 27 Dec 2023
Clinical pharmacist interventions in the transition of care in a mental health hospital: case reports focused on the medication reconciliation process
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2023.1263464
- 3,847 views
- 13 citations
Original Research
Published on 12 Dec 2023
Trends in antipsychotic use among children and adolescents in Germany: a study using 2011–2020 nationwide outpatient claims data
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2023.1264047
- 6,642 views
- 3 citations
Mini Review
Published on 08 Dec 2023
Short-term ketamine use in bipolar depression: a review of the evidence for short-term treatment management
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2023.1322752
- 9,064 views
- 7 citations
Editorial
Published on 06 Dec 2023
Editorial: Safety and side effects of psychotropic medications, volume II
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2023.1326118
- 1,712 views
- 2 citations
Review
Published on 05 Dec 2023
Zuranolone – synthetic neurosteroid in treatment of mental disorders: narrative review
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2023.1298359
- 19,230 views
- 16 citations
Case Report
Published on 28 Nov 2023
Clinical case report: considerable improvement of severe and difficult-to-treat obsessive-compulsive disorder with comorbid depression under treatment with esketamine and concomitant psychotherapy
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2023.1291077
- 6,004 views
- 1 citation